| EIN2-directed translational regulation of ethylene signaling in Arabidopsis W Li, M Ma, Y Feng, H Li, Y Wang, Y Ma, M Li, F An, H Guo Cell 163 (3), 670-683, 2015 | 338 | 2015 |
| A suitable zeolite Rho for separating CO2/CH4 in pressure swing adsorption (PSA) process D Liang, Y Hu, Q Bao, J Zhang, J Feng, P Sun, Y Ma, H Zhang Inorganic Chemistry Communications 127, 108547, 2021 | 30 | 2021 |
| Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer H Wen, Z Feng, Y Ma, R Liu, Q Ou, Q Guo, Y Shen, X Wu, Y Shao, H Bao, ... BMC cancer 22 (1), 550, 2022 | 28 | 2022 |
| Utilizing phenotypic characteristics of metastatic brain tumors to improve the probability of detecting circulating tumor DNA from cerebrospinal fluid in non-small-cell lung … M Li, X Hou, L Zheng, Y Ma, D Li, Y Lv, J Chen, W Zheng, Y Shao, Y Mou, ... ESMO open 7 (1), 100305, 2022 | 16 | 2022 |
| Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling L Lin, Q Lu, R Cao, Q Ou, Y Ma, H Bao, X Wu, Y Shao, Z Wang, B Shen American Journal of Cancer Research 10 (11), 4005, 2020 | 16 | 2020 |
| A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas X Wang, W Su, Y Gao, Y Feng, X Wang, X Chen, Y Hu, Y Ma, Q Ou, ... Haematologica 107 (9), 2154, 2022 | 15 | 2022 |
| Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer W Li, L Guo, W Tang, Y Ma, X Wang, Y Shao, H Zhao, J Ying Clinical epigenetics 13 (1), 126, 2021 | 15 | 2021 |
| Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden Y Cao, Y Ma, J Yu, Y Sun, T Sun, Y Shao, J Li, L Shen, M Lu Cancer Communications 40 (12), 746-751, 2020 | 15 | 2020 |
| Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response J Li, Q Wei, X Wu, J Sima, Q Xu, M Wu, F Wang, H Mou, H Hu, J Zhao, ... Clinical and Translational Medicine 10 (4), e118, 2020 | 15 | 2020 |
| Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor responses … M Li, J Chen, B Zhang, J Yu, N Wang, D Li, Y Shao, D Zhu, C Liang, Y Ma, ... BMC medicine 20 (1), 398, 2022 | 14 | 2022 |
| The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification Y Yang, Y Ding, Y Gong, S Zhao, M Li, X Li, G Song, B Zhai, J Liu, Y Shao, ... BMC cancer 22 (1), 186, 2022 | 12 | 2022 |
| Mixed responses to first‐line alectinib in non‐small cell lung cancer patients with rare ALK gene fusions: A case series and literature review M Li, Z An, Q Tang, Y Ma, J Yan, S Chen, Y Wang Journal of Cellular and Molecular Medicine 25 (19), 9476-9481, 2021 | 11 | 2021 |
| Utilizing metagenomic next-generation sequencing (mNGS) for rapid pathogen identification and to inform clinical decision-making: results from a large real-world cohort J Xu, P Zhou, J Liu, L Zhao, H Fu, Q Han, L Wang, W Wu, Q Ou, Y Ma, ... Infectious Diseases and Therapy 12 (4), 1175-1187, 2023 | 9 | 2023 |
| Clinical significance of ERBB2 exon 16 skipping: analysis of a real-world retrospective observational cohort study L Shi, C Xu, Y Ma, Q Ou, X Wu, S Lu, Y Shao, R Guo, J Kong ESMO open 5 (6), e000985, 2020 | 6 | 2020 |
| An Effective Hormonal Therapy for a Patient with Estrogen Receptor 1 (ESR1)-Amplified Metastatic Ovarian Cancer: A Case Report Y Wang, S Tan, E Pan, Y Ma, X Wu, Z Yu, K Jiang OncoTargets and therapy, 643-649, 2022 | 4 | 2022 |
| Characterizing kinase intergenic-breakpoint rearrangements in a large-scale lung cancer population and real-world clinical outcomes Y Yao, Z Yu, Y Ma, Q Ou, X Wu, D Lu, X Li ESMO open 7 (2), 100405, 2022 | 3 | 2022 |
| Simultaneous diagnosis of tuberculous pleurisy and malignant pleural effusion using metagenomic next-generation sequencing (mNGS) F Xu, Q Wang, N Zhang, X Xing, Z Liu, K Li, Y Ma, Q Ou, Y Jia, X Chen, ... Journal of Translational Medicine 21 (1), 680, 2023 | 2 | 2023 |
| Correction: Dynamic monitoring of cerebrospinal fluid circulating tumor DNA to identify unique genetic profiles of brain metastatic tumors and better predict intracranial tumor … M Li, J Chen, B Zhang, J Yu, N Wang, D Li, Y Shao, D Zhu, C Liang, Y Ma, ... BMC medicine 21, 2023 | 2 | 2023 |
| Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report J Ye, Y Ma, Q Ou, J Yan, B Ye, Y Li Frontiers in Oncology 12, 883367, 2022 | 2 | 2022 |
| Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors D Yang, D Li, Z Dai, Y Ma, Q Ou, X Wu, S Cui Cancer Communications 41 (2), 183, 2021 | 2 | 2021 |
